Comparison between Arvee Laboratories IPO and Hindcon Chemicals IPO.
Arvee Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Hindcon Chemicals IPO is a SME Fixed Price proposed to list at NSE SME.
| Arvee Laboratories IPO | Hindcon Chemicals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Sarthi Capital Advisors Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Wealth First Portfolio Managers Pvt.Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Arvee Laboratories IPO is up to ₹8.44 Cr whereas the issue size of the Hindcon Chemicals IPO is up to ₹7.32 Cr. The final issue price of Arvee Laboratories IPO is ₹61.00 per share and of Hindcon Chemicals IPO is ₹28.00 per share.
| Arvee Laboratories IPO | Hindcon Chemicals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹61.00 per share | ₹28.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 13,84,000 shares | 26,16,000 shares |
| Fresh Issue Size (Amount) | up to ₹8.44 Cr | up to ₹7.32 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,84,000 shares | 26,16,000 shares |
| Issue Size Total (Amount) | up to ₹8.44 Cr | up to ₹7.32 Cr |
Arvee Laboratories IPO opens on Feb 09, 2018, while Hindcon Chemicals IPO opens on Feb 26, 2018. The closing date of Arvee Laboratories IPO and Hindcon Chemicals IPO is Feb 14, 2018, and Feb 28, 2018, respectively.
| Arvee Laboratories IPO | Hindcon Chemicals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 09, 2018 | Feb 26, 2018 |
| Issue Close | Feb 14, 2018 | Feb 28, 2018 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 22, 2018 | Mar 09, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Arvee Laboratories IPO P/E ratio is , as compared to Hindcon Chemicals IPO P/E ratio of .
| Arvee Laboratories IPO | Hindcon Chemicals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹33.61 Cr. | ₹28.67 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Arvee Laboratories IPO Retail Individual Investors (RII) are offered 6,92,000 shares while in Hindcon Chemicals IPO retail investors are offered 6,92,000 shares. Qualified Institutional Buyers (QIB) are offered in Arvee Laboratories IPO and in Hindcon Chemicals IPO.
| Arvee Laboratories IPO | Hindcon Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 76,000 shares | 1,44,000 shares |
| QIB | ||
| NII | 6,92,000 shares | 13,08,000 shares |
| RII | 6,92,000 shares | 13,08,000 shares |
| Employee | ||
| Others | ||
| Total | 13,84,000 shares | 26,16,000 shares |
Arvee Laboratories IPO subscribed 2.90x in total, whereas Hindcon Chemicals IPO subscribed 137.63x.
| Arvee Laboratories IPO | Hindcon Chemicals IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.18x | 154.85x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.62x | 120.41x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.90x | 137.63x |
